Obagi Nu-Derm System Normal-Oily Skin Transformation Trial
Generic: Hydroquinone, Homosalate, Octisalate, Zinc Oxide
- Manufacturer
- Obagi
- NDC
- 62032-914
- RxCUI
- 197795
- ICD-10 indication
- L57.9
Affordability Check
How much will you actually pay for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial?
In 30 seconds, see every legitimate way to afford Obagi Nu-Derm System Normal-Oily Skin Transformation Trial — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Obagi Nu-Derm System Normal-Oily Skin Transformation Trial
What is this medication? The Obagi Nu-Derm System for normal to oily skin is a comprehensive, prescription-strength skincare regimen designed to transform aging or damaged skin. It works at the cellular level to correct visible signs of photoaging, such as dark spots, hyperpigmentation, melasma, and uneven skin tone. By targeting the skin's natural functions, the system helps to accelerate cellular turnover and improve the overall texture and clarity of the complexion.
This specific trial kit is tailored for individuals with oily or normal skin textures, utilizing specialized formulas like the foaming gel cleanser and Exfoderm Forte to manage excess oil and promote exfoliation. The primary active ingredients often include hydroquinone to lighten discolorations and penetrate the skin layers effectively. Regular use of the system helps to reveal a more youthful, healthy-looking appearance by restoring skin elasticity and reducing the prominence of fine lines and wrinkles.
Copay & patient assistance
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Hydroquinone, Homosalate, Octisalate, Zinc Oxide.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Obagi Nu-Derm System Normal-Oily Skin Transformation Trial →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Hydroquinone, Homosalate, Octisalate, Zinc Oxide →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Prescribing information
From the FDA-approved label for Obagi Nu-Derm System Normal-Oily Skin Transformation Trial. Official source: DailyMed (NLM) · Label effective Oct 23, 2025
Indications and usage
Dosage and administration
Warnings
Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
Obagi Nu-Derm System Normal-Oily Skin Transformation
Same generic · HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE
Obagi Nu-Derm System Normal-Dry Skin Transformation Kit
Same generic · Hydroquinone, Homosalate, Octisalate, Zinc Oxide
EVEROLIMUS
Treats same condition · Everolimus
AVMAPKI FAKZYNJA CO-PACK
Treats same condition · avutometinib potassium and defactinib hydrochloride
Fludeoxyglucose F18
Treats same condition · Fludeoxyglucose F18
Portrazza
Treats same condition · necitumumab
Pilocarpine Hydrochloride
Treats same condition · Pilocarpine Hydrochloride
TEPADINA
Treats same condition · THIOTEPA
AVGEMSI
Treats same condition · Gemcitabine
CLENPIQ
Treats same condition · SODIUM PICOSULFATE, MAGNESIUM OXIDE, and ANHYDROUS CITRIC ACID
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.